Ocugen Inc (NASDAQ: OCGN) kicked off on Friday, down -5.83% from the previous trading day, before settling in for the closing price of $1.20. Over the past 52 weeks, OCGN has traded in a range of $0.51-$1.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -15.00%. With a float of $286.77 million, this company’s outstanding shares have now reached $292.03 million.
In an organization with 95 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -1261.43%, and the pretax margin is -1271.12%.
Ocugen Inc (OCGN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 26.40%. The most recent insider transaction that took place on Jun 11 ’25, was worth 171,029. Before that another transaction happened on Nov 26 ’24, when Company’s Director bought 10,000 for $0.91, making the entire transaction worth $9,095. This insider now owns 10,000 shares in total.
Ocugen Inc (OCGN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 46.87% during the next five years compared to 32.82% growth over the previous five years of trading.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Take a look at Ocugen Inc’s (OCGN) current performance indicators. Last quarter, stock had a quick ratio of 2.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 73.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Let’s dig in a bit further. During the last 5-days, its volume was 5.85 million. That was better than the volume of 4.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 82.38%. Additionally, its Average True Range was 0.09.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 84.83%, which indicates a significant increase from 75.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.65% in the past 14 days, which was lower than the 83.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7929, while its 200-day Moving Average is $0.8439. However, in the short run, Ocugen Inc’s stock first resistance to watch stands at $1.1667. Second resistance stands at $1.2033. The third major resistance level sits at $1.2367. If the price goes on to break the first support level at $1.0967, it is likely to go to the next support level at $1.0633. Assuming the price breaks the second support level, the third support level stands at $1.0267.
Ocugen Inc (NASDAQ: OCGN) Key Stats
The company with the Market Capitalisation of 330.00 million has total of 292,031K Shares Outstanding. Its annual sales at the moment are 4,060 K in contrast with the sum of -54,050 K annual income. Company’s last quarter sales were recorded 1,480 K and last quarter income was -15,350 K.
